Startups

The 10 largest biotech and devices VC investments in Q2

The most recent MoneyTree report from PwC and CB Insights highlights the biggest biotech-related and medical devices VC deals in Q2, which include investments in companies like Grail, Allogene Therapeutics, RefleXion Medical and Mevion Medical Systems.

time is money

The latest MoneyTree report from PricewaterhouseCoopers and CB Insights found that within the second quarter of 2018, there was $5.3 billion invested in 216 deals in the healthcare sector. This is an uptick from Q2 2017, when there was $3 billion invested in 179 deals.

Additionally, the research notes that healthcare accounted for 15 percent of total U.S. deal activity in Q2. The industry made up 14 percent of activity in Q1 2018 and 13 percent of activity in Q2 2017.

Diving deeper into the data, the report outlines the 10 largest biotech-related VC investments that happened during Q2 of this year:

Company: Allogene Therapeutics
Location: South San Francisco, California
Amount raised: $300 million
Investors: BellCo Capital, TPG Capital, University of California, Vida Ventures

Company: Grail
Location: Menlo Park, California
Amount raised: $300 million
Investors: 6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, China Merchants Securities, CRF Investment, Hillhouse Capital Management, HuangPu River Capital, ICBC International, Sequoia Capital China, WuXi NextCODE

Company: Brii BioSciences
Location: Durham, North Carolina
Amount raised: $260 million
Investors: 6 Dimensions Capital, ARCH Venture Partners, Blue Pool Capital, Boyu Capital, Sequoia Capital China, Yunfeng Capital

Company: Moderna Therapeutics
Location: Cambridge, Massachusetts
Amount raised: $125 million
Investors: Merck

Company: Precision BioSciences
Location: Durham, North Carolina
Amount raised: $110 million
Investors: Adage Capital Management, Agent Capital, Alexandria Venture Investments, Amgen Ventures, ArrowMark Partners, Brace Pharma Capital, Cormorant Asset Management, Cowen Group, DUMAC, F-Prime Capital, Franklin Templeton Investments, Gilead Sciences, Leerink Partners, OCV Partners, Osage University Partners, Pontifax AgTech, RA Capital Management, Ridgeback Capital Management, The Longevity Fund, venBIO, Vivo Capital

CompanyKaleido Biosciences
Location: Bedford, Massachusetts
Amount raised: $101 million
Investors: Abu Dhabi Investment Authority, Fidelity Investments, Flagship Pioneering, Invus Group, Rock Springs Capital

Company: Constellation Pharmaceuticals
Location: Cambridge, Massachusetts
Amount raised: $100 million
Investors: Casdin Capital; Cormorant Asset Management, Deerfield Management, Fidelity Investments, Hillhouse Capital Management, NS Investment, OrbiMed Advisors, Sirona Capital, SR One, The Column Group, Third Rock Ventures, Topspin Partners, University Of California, Venrock

Company: Stealth BioTherapeutics
Location: Newton, Massachusetts
Amount raised: $100 million
Investors: Atlantis Investment Management, BVCF, CMBC Capital Holdings, Kingdon Capital Management, Morningside Ventures, Nan Fung, Ocean Equity Partners, Sagamore Investments

Company: PACT Pharma
Location: Hayward, California
Amount raised: $95 million
Investors: Canaan Partners, Casdin Capital, Google Ventures, Invus Group

Company: Beam Therapeutics
Location: Cambridge, Massachusetts
Amount raised: $87 million
Investors: ARCH Venture Partners, F-Prime Capital

The MoneyTree report also pinpoints the 10 outlines the 10 biggest medical devices and equipment VC deals from Q2:

Company: Mevion Medical Systems
Location: Littleton, Massachusetts
Amount raised: $150 million
Investors: China Everbright International, Henan Maisheng Medical Technology, Hopu Investment Management. Undisclosed Private Equity Investors, YuanMing Capital

Company: RefleXion Medical
Location: Hayward, California
Amount raised: $100 million
Investors: GT Healthcare Capital Partners, Johnson & Johnson Innovation, KCK Group, Pfizer Venture Investments, Sofinnova Partners, T. Rowe Price, The Rise Fund, Venrock

Company: Relievant Medsystems
Location: Minneapolis, Minnesota
Amount raised: $58 million
Investors: Canaan Partners, Emergent Medical Partners, Endeavour Vision, Lightstone Ventures, New Enterprise Associates, Richard King Mellon Foundation Endowment Fund

Company: Cardiac Dimensions
Location: Kirkland, Washington
Amount raised: $39 million
Investors: Aperture Venture Partners, Arboretum Ventures, Hostplus, Life Sciences Partners, Lumira Capital, M.H. Carnegie & Co., Oxford Finance

Company: Cytrellis Biosystems
Location: Woburn, Massachusetts
Amount raised: $28.5 million
Investors: ARCH Venture Partners, Biomatics Capital Partners, Merz Ventures, Partner Fund Management

Company: Avedro
Location: Waltham, Massachusetts
Amount raised: $25 million
Investors: De Novo Ventures, HealthQuest Capital, InterWest Partners, Lilly Asia Ventures, OrbiMed Advisors, SV Health Investors

Company: Acutus Medical
Location: Carlsbad, California
Amount raised: $22.82 million
Investors: Advent Life Sciences, Deerfield Management, OrbiMed Advisors, Xeraya Capital

Company: Eargo
Location: Mountain View, California
Amount raised: $22.12 million
Investors: Novo A/S

Company: CardioFocus
Location: Marlborough, Massachusetts
Amount raised: $21 million
Investors: GPB Capital Holdings

Company: Axonics Modulation Technologies
Location: Irvine, California
Amount raised: $20.1 million
Investors: Gilde Healthcare Partners, Longitude Capital

Photo: Warchi, Getty Images